Diuretics

Diuretics lower blood pressure by promoting renal excretion of sodium and water, reducing blood volume and, over time, peripheral vascular resistance. The main classes act at different nephron segments: thiazides at the distal convoluted tubule, loop diuretics at the thick ascending limb, and potassium-sparing agents at the collecting duct.

Definition

Diuretics are drugs that increase urinary excretion of sodium and water by inhibiting sodium reabsorption at defined segments of the renal tubule, lowering blood volume and, with chronic use, vascular resistance.

Scope

This entry covers how diuretics act at specific nephron transporters to produce natriuresis, the differences among thiazide, loop, and potassium-sparing classes, and the long-standing outcome evidence supporting low-dose thiazide-type diuretics in hypertension. It is reference material, not prescribing guidance.

Core questions

• How does inhibiting sodium reabsorption at the nephron lower blood pressure?
• How do thiazide, loop, and potassium-sparing diuretics differ in site and effect?
• What does long-term outcome evidence show for thiazide-type diuretics?

Key concepts

• Natriuresis and sodium-volume balance
• Thiazides and the distal convoluted tubule
• Loop diuretics and the thick ascending limb
• Potassium-sparing diuretics and the collecting duct
• Initial volume reduction versus chronic vasodilation
• Electrolyte and metabolic effects

Mechanisms

Diuretics inhibit sodium reabsorption at specific nephron segments. Thiazide and thiazide-like agents block the sodium-chloride cotransporter in the distal convoluted tubule; loop diuretics block the sodium-potassium-chloride cotransporter in the thick ascending limb and are the most potent natriuretics; potassium-sparing agents act at the collecting duct, either blocking the epithelial sodium channel or antagonising aldosterone. The resulting natriuresis lowers blood volume and cardiac output initially; with continued use, blood pressure stays reduced largely through a fall in peripheral vascular resistance. Sodium loss can be accompanied by potassium and other electrolyte changes that characterise each class.

Clinical relevance

Diuretics are central to understanding renal control of blood volume and are among the most studied antihypertensive agents, with thiazide-type drugs prominent in long-term trials. This entry describes their mechanism and evidence as educational reference and does not provide dosing or individualised treatment advice.

Evidence & guidelines

Thiazide and thiazide-like diuretics are first-line antihypertensive options in major guidelines, supported by decades of outcome trials. SHEP showed that a thiazide-based regimen reduced stroke in older adults with isolated systolic hypertension, and ALLHAT found a thiazide-type diuretic at least as effective as a calcium channel blocker or ACE inhibitor for major cardiovascular outcomes, reinforcing the class's first-line position.

History

Modern diuretic therapy began with the carbonic anhydrase inhibitors and was transformed by the introduction of chlorothiazide in the 1950s, the first orally effective thiazide, followed by loop diuretics and potassium-sparing agents. Large hypertension trials over subsequent decades established thiazide-type diuretics as foundational antihypertensive drugs.

Seminal works

• shep-1991
• allhat-2002
• subramanya-2014

Frequently asked questions

Why are thiazide diuretics used so widely for blood pressure?

Thiazide-type diuretics have decades of outcome-trial evidence, including SHEP and ALLHAT, showing they reduce cardiovascular events, and guidelines list them among first-line antihypertensive classes.

How do loop diuretics differ from thiazides?

Loop diuretics act on the thick ascending limb and produce more powerful natriuresis, while thiazides act on the distal convoluted tubule; the two classes target different transporters at different nephron segments.